SCHEMBL4508963

SCHEMBL4508963

CC(C)(CO)N1CCCC1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.40
BRD2 P25440 1/20 0.40
LMNA P02545 3/20 0.38
PIK3CD O00329 1/20 0.37
KMT2A Q03164 2/20 0.37
TSHR P16473 2/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA3 P07451 1/20 0.36
CA4 P22748 1/20 0.36
CA6 P23280 1/20 0.36
CA5A P35218 1/20 0.36
CA7 P43166 1/20 0.36
CA9 Q16790 1/20 0.36
CA13 Q8N1Q1 1/20 0.36
CA14 Q9ULX7 1/20 0.36
CA5B Q9Y2D0 1/20 0.36
PER2 O15055 2/20 0.34
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10093754 0.82 BRD4 (0.41) BRD4BRD2LMNAPIK3CDKMT2A
SCHEMBL21465976 0.80 BRD4 (0.40) BRD4BRD2LMNAPIK3CDKMT2A
SCHEMBL11028251 0.80 BRD4 (0.40) BRD4BRD2LMNAPIK3CDKMT2A
SCHEMBL6606439 0.80 BRD4 (0.40) BRD4BRD2LMNAPIK3CDKMT2A
SCHEMBL25988587 0.78 BRD4 (0.39) BRD4BRD2LMNAPIK3CDKMT2A
SCHEMBL19918791 0.78 BRD4 (0.39) BRD4BRD2LMNAPIK3CDKMT2A
SCHEMBL6608794 0.77 BRD4 (0.38) BRD4BRD2LMNAPIK3CDKMT2A
SCHEMBL19106731 0.77 PIK3CD (0.47) BRD4BRD2LMNAPIK3CDKMT2A
SCHEMBL23854239 0.77 BRD4 (0.44) BRD4BRD2LMNAPIK3CDKMT2A
SCHEMBL10664045 0.77 BRD4 (0.44) BRD4BRD2LMNAPIK3CDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4397750-A ALKENYLSUCCINIC AHYDRIDE DERIVATIVES MOBIL OIL CORPORATION (US) 1983-08-09 US claimed
US-20210332254-A1 Aqueous Ink Jet Compostion And Method For Manufacturing Recorded Matter SEIKO EPSON CORPORATION (JP) 2021-10-28 US disclosed
US-20210301165-A1 Aqueous Ink Jet Composition, Ink Set, Ink Jet Recording Apparatus, And Method For Manufacturing Recorded Matter SEIKO EPSON CORPORATION (JP) 2021-09-30 US disclosed
US-20090264650-A1 Prophylactic/Therapeutic Agent for Diabetes TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-10-22 US disclosed
EP-1864971-A1 PROPHYLACTIC/THERAPEUTIC AGENT FOR DIABETES Takeda Pharmaceutical Company Limited (JP) 2007-12-12 EP disclosed
US-4397750-A ALKENYLSUCCINIC AHYDRIDE DERIVATIVES MOBIL OIL CORPORATION (US) 1983-08-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090264650-A1 Prophylactic/Therapeutic Agent for Diabetes HSD11B1, HSD17B1, HSD11B2 BRD4 3776/4885BRD2 3616/4885LMNA 2846/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.